000 | 01019nam a2200157Ia 4500 | ||
---|---|---|---|
008 | 220515s9999||||xx |||||||||||||| ||und|| | ||
020 | _a92 4 154641 7 | ||
050 | _aQV 77.2 .W46 2005 | ||
110 | _aWorld Health Organization | ||
245 | 0 | _aImproving access and use of psychotropic medicines | |
260 |
_aGeneva _bWorld Health Organization _c2005 |
||
300 | _axi, 58p. | ||
500 | _aDiscuses how to improve access to essential medicines for mental disorders, which are often referred to as "essential psychotropic medicines" or "essential psychotropics". It is intended for use by policy-makers and public health professionals of national ministries of health and large administrative divisions of countries in charge of planning improvements in mental health systems. This book deals with the availability of psychotropic medicines, their affordability, their financing and their appropriate use. | ||
650 | _aMental Disorders|Psychotropic Drugs|Public Policy|Public Health|World Health Organization | ||
942 |
_2lcc _cBK |
||
999 |
_c406 _d406 |